Yisheng Biopharma Co., Ltd

Asia & Pacific Legal Chronicle. April 4, 2022

Yisheng Biopharma Co., Ltd.’s US$40 Million Royalty-Backed Financing From R-Bridge Healthcare Fund

By Giulia Di Palma

Clifford Chance has advised Yisheng Biopharma Co., Ltd. on the deal, while Sidley Austin LLP and Maples and Calder advised R-Bridge Healthcare Fund. Yisheng Biopharma Co.,...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

OneMain Financial’s $900 Million Senior Unsecured Notes Offering

Insider’s $500 Million Series E Financing Round

Edison International’s $550 Million Notes Offering

Crescera Capital’s Acquisition of Segware

Reddy Ice’s Acquisition of Aguafría

‘Mercado Crédito XXVII’ Financial Trusts’ Issuance

Vulcan Energie’s Acquisition Of geox GmbH From IKAV Group

Pezzutti Group’s Corporate Reorganization

Oddlygood’s Acquisition of Rude Health

Camusat Holding’s €81 Million Mezzanine Investment Round

Retail Holding’s Shareholders Reconfiguration

Ora Developers Egypt for Real Estate Investment’s Financing Round

Fourth Milling Company’s Initial Public Offering on Tadawul

A101 Yeni Magazacilik A.S.’ $200 Million Sustainability Loan

ADNH Catering’s US$235 Million Initial Public Offering

Sembcorp Industries’ Notes Issuance

Suven Pharmaceuticals’ Merger with Casper Pharma

HomeLane’s Acquisition of DesignCafe

Senior M&A Lawyer Deepa Vallabh Joins Bowmans in Johannesburg

Michael R. Guerrero Returns to Hinshaw’s Consumer Financial Services Group in California

James Barbaria Joins Hinshaw & Culbertson LLP as Chief Financial Officer

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

Senior M&A Lawyer Deepa Vallabh Joins Bowmans in Johannesburg

Michael R. Guerrero Returns to Hinshaw’s Consumer Financial Services Group in California

James Barbaria Joins Hinshaw & Culbertson LLP as Chief Financial Officer

Yisheng Biopharma Co., Ltd.’s US$40 Million Royalty-Backed Financing From R-Bridge Healthcare Fund

Standard 1 Year Membership Required